BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27380930)

  • 1. Dense red blood cell and oxygen desaturation in sickle-cell disease.
    Di Liberto G; Kiger L; Marden MC; Boyer L; Poitrine FC; Conti M; Rakotoson MG; Habibi A; Khorgami S; Vingert B; Maitre B; Galacteros F; Pirenne F; Bartolucci P
    Am J Hematol; 2016 Oct; 91(10):1008-13. PubMed ID: 27380930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.
    Seakins M; Gibbs WN; Milner PF; Bertles JF
    J Clin Invest; 1973 Feb; 52(2):422-32. PubMed ID: 4683881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological parameters predictive of percent dense red blood cell decrease under hydroxyurea.
    Rakotoson MG; Di Liberto G; Audureau E; Habibi A; Fauroux C; Khorgami S; Hulin A; Loric S; Noizat-Pirenne F; Galacteros F; Bartolucci P
    Orphanet J Rare Dis; 2015 May; 10():57. PubMed ID: 25956133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.
    Head CA; Brugnara C; Martinez-Ruiz R; Kacmarek RM; Bridges KR; Kuter D; Bloch KD; Zapol WM
    J Clin Invest; 1997 Sep; 100(5):1193-8. PubMed ID: 9276736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of deoxygenation modulates rheologic behavior of sickle red blood cells at a given mean corpuscular hemoglobin concentration.
    Kaul DK; Liu XD
    Clin Hemorheol Microcirc; 1999; 21(2):125-35. PubMed ID: 10599596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry.
    Rab MAE; van Oirschot BA; Bos J; Kanne CK; Sheehan VA; van Beers EJ; van Wijk R
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31762454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
    Rab MAE; van Oirschot BA; Bos J; Merkx TH; van Wesel ACW; Abdulmalik O; Safo MK; Versluijs BA; Houwing ME; Cnossen MH; Riedl J; Schutgens REG; Pasterkamp G; Bartels M; van Beers EJ; van Wijk R
    Am J Hematol; 2019 May; 94(5):575-584. PubMed ID: 30784099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis.
    Bartolucci P; Brugnara C; Teixeira-Pinto A; Pissard S; Moradkhani K; Jouault H; Galacteros F
    Blood; 2012 Oct; 120(15):3136-41. PubMed ID: 22919030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
    Schroeder P; Fulzele K; Forsyth S; Ribadeneira MD; Guichard S; Wilker E; Marshall CG; Drake A; Fessler R; Konstantinidis DG; Seu KG; Kalfa TA
    J Pharmacol Exp Ther; 2022 Mar; 380(3):210-219. PubMed ID: 35031585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
    Hebert N; Rakotoson MG; Bodivit G; Audureau E; Bencheikh L; Kiger L; Oubaya N; Pakdaman S; Sakka M; Di Liberto G; Chadebech P; Vingert B; Pirenne F; Galactéros F; Cambot M; Bartolucci P
    Am J Hematol; 2020 Nov; 95(11):1235-1245. PubMed ID: 32681733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease.
    Maier-Redelsperger M; Noguchi CT; de Montalembert M; Rodgers GP; Schechter AN; Gourbil A; Blanchard D; Jais JP; Ducrocq R; Peltier JY
    Blood; 1994 Nov; 84(9):3182-8. PubMed ID: 7524767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.
    Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR
    Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells.
    Nakagawa A; Ferrari M; Schleifer G; Cooper MK; Liu C; Yu B; Berra L; Klings ES; Safo RS; Chen Q; Musayev FN; Safo MK; Abdulmalik O; Bloch DB; Zapol WM
    Mol Pharm; 2018 May; 15(5):1954-1963. PubMed ID: 29634905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of blood from patients with sickle cell disease to air changes the morphological, oxygen-binding, and sickling properties of sickled erythrocytes.
    Obata K; Mattiello J; Asakura K; Ohene-Frempong K; Asakura T
    Am J Hematol; 2006 Jan; 81(1):26-35. PubMed ID: 16369974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling.
    De Souza DC; Hebert N; Esrick EB; Ciuculescu MF; Archer NM; Armant M; Audureau É; Brendel C; Di Caprio G; Galactéros F; Liu D; McCabe A; Morris E; Schonbrun E; Williams D; Wood DK; Williams DA; Bartolucci P; Higgins JM
    Nat Commun; 2023 Sep; 14(1):5850. PubMed ID: 37730674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filterability of freshly-collected sickle erythrocytes under venous oxygen pressure without exposure to air.
    Shah S; Acholonu RG; Ohene-Frempong K; Asakura T
    Blood Cells Mol Dis; 2015 Dec; 55(4):328-35. PubMed ID: 26460256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice.
    Shrestha A; Chi M; Wagner K; Malik A; Korpik J; Drake A; Fulzele K; Guichard S; Malik P
    Blood Adv; 2021 May; 5(9):2385-2390. PubMed ID: 33944896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular hemoglobin S polymerization and the clinical severity of sickle cell anemia.
    Poillon WN; Kim BC; Castro O
    Blood; 1998 Mar; 91(5):1777-83. PubMed ID: 9473246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous polymerization and adhesion under hypoxia in sickle cell disease.
    Papageorgiou DP; Abidi SZ; Chang HY; Li X; Kato GJ; Karniadakis GE; Suresh S; Dao M
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9473-9478. PubMed ID: 30190429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.